• 1
    Dykewicz CA. Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Clin Infect Dis 2001: 33: 139.
  • 2
    Harris AD, Samore MH, Lipsitch M, Kaye KS, Perencevich E, Carmeli Y. Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. Clin Infect Dis 2002: 34: 1558.
  • 3
    Swierkosz EM, Hodinka RL, Moore BM, Sacks S, Scholl DR, Wright DK. Antiviral Susceptibility Testing: Herpes Simplex Virus by Plaque Reduction Assay; Approved Standard. NCCLS document M33-A. Wayne, PA: NCCLS, 2004.
  • 4
    Brisebois JJ, Dumas VM, Joncas JH. Comparison of two methods in the determination of the sensitivity of 84 herpes simplex virus (HSV) type 1 and 2 clinical isolates to acyclovir and alpha-interferon. Antiviral Res 1989: 11: 67.